Larry Brown
Chief Scientific Officer Noveome Biotherapeutics
Seminars
Wednesday 3rd February 2027
Unlocking the Potential of Nose-to-Brain Biologic Delivery for Neuroprotection in CNS Disorders
12:00 pm
- Exploring how intranasal delivery can bypass the blood-brain barrier to enable direct access to the central nervous system
- Examining the opportunities and challenges of developing potent biologics for neurodegenerative diseases including Alzheimer’s, Parkinson’s, and ALS
- Understanding the scientific, clinical, and commercial considerations needed to drive broader adoption of nose-to-brain therapeutics
Wednesday 3rd February 2027
Panel Discussion: Has the Industry Finally Solved Nose-to-Brain Delivery?
5:00 pm
- Identify the critical scientific, translational, and clinical evidence gaps that remain before nose-to brain delivery can achieve widespread regulatory acceptance and commercial adoption
- Understand what regulators still need to see regarding reproducibility, biodistribution, imaging, clinical outcomes, and direct CNS exposure before confidently supporting nose-to-brain claims
- Debate whether current preclinical models, analytical tools, imaging technologies, and translational approaches are sufficient to predict human outcomes and support development decisions
- Separate genuine scientific progress from industry hype by examining which technologies, pathways, and approaches are producing meaningful evidence versus those that continue to face significant validation challenges
